David R. Scholl

Dr. Scholl, PhD, joined Athenian Venture Partners as a scientific consultant in 1997. He then became a part-time partner in the firm’s Healthcare practice in 2000. Dr. Scholl has over 35 years Healthcare experience in venture capital, research and development and operating management. Prior to his initial years consulting for Athenian, Dr. Scholl served as CEO of Diagnostic Hybrids (“DHI”), taking it from start-up to a $138MM company before merging it with Quidel Corporation (Nasdaq: QDEL) in 2010. After completing the integration as a Senior Vice President of Commercial Operations, he retired from Quidel in October 2011. Dr. Scholl has since transitioned to a more active role at Athenian. As part of the founding team of DHI in 1983, Dr. Scholl was instrumental in driving DHI’s research and development and market adoption of numerous industry-leading commercial products. In 1997, Dr. Scholl became President and CEO of the company and successfully built its manufacturing, sales and business development infrastructure. In so doing, he forged long-term relationships with the company’s key stakeholders and raised $15M in equity growth capital, with Summit Partners (Palo Alto) and Ohio University Foundation as major equity partners. At Athenian, Dr. Scholl has worked on a wide range of healthcare investment opportunities including biopharmaceuticals, gene delivery technology, genomics, bio-imaging technology tissue engineering and cancer therapeutics. Dr. Scholl has been appointed to serve on numerous boards, including two terms as Chairman of BioOhio, a three-year term as a voting Commissioner on the Ohio Third Frontier Commission, and a nine-year term as a member of the Ohio University Board of Trustees. He also formerly served as a trustee of the Ohio University Foundation. In addition, Dr. Scholl was a founding board member of the Ohio Business Development Coalition (OBDC) Board for Appalachia Ohio and served for six years as president of FIRST, The Foundation for Ichthyosis and Related Skin Types, Inc.™ (Philadelphia, PA). Given his experience and accomplishments in the space, he was the proud recipient of the Central Ohio Ernst and Young Entrepreneur of the Year Award in Healthcare in 2003. Dr. Scholl was a Post-Doctoral Research Fellow at the Roche Institute for Molecular Biology (Nutley, NJ), after completing a PhD in Microbiology at Ohio University in Athens, OH. He earned a BS in Biology from Indiana University.